$NGVT

Ingevity Corp

2
0
0
$200K
Fisher Ryan C.
0%
Med

Ingevity (NGVT) Q2 2026 Earnings Call Transcript

Ingevity (NGVT) held its Q2 2026 earnings call. Net sales were $314 million, down 5% on reported basis due to the Road Markings divestiture. Adjusted EBITDA rose 14% to $115 million, with margin at 36.6%. Adjusted EPS was $1.74. Free cash flow was $89 million. Full-year guidance for EBITDA and EPS was raised.

Fisher Ryan C. sold $200K of NGVT

Fisher Ryan C. (SVP, Gen. Counsel & Secretary) sold 2,709 shares of Ingevity Corp (NGVT) at an average of $73.72 ($73.67–$73.76, $0.20M total) across 2 trades on 2026-08-03.

Ingevity Q2 Earnings Call Highlights

Ingevity (NYSE:NGVT) reported Q2 cash flow excluding a litigation settlement of about $89M, or $2.52/share, with capex near $10M. Performance Materials sales rose 4% to $161M, with segment EBITDA up 6% to $86M and margin to 53.6%. The company raised 2026 outlook to adjusted EBITDA $380M-$400M and EPS $5.00-$5.45, plus free cash flow $220M-$245M.

NGVT sentiment & insider activity

Over the past 7 days, alphai's AI scored 2 news stories mentioning NGVT (Ingevity Corp). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.

Recent NGVT coverage spans insider activity, earnings and financial news.

In the last 30 days, NGVT insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($200K). The most active reporter was Fisher Ryan C., SVP, Gen. Counsel & Secretary, with 2 filings.

What's driving NGVT

  • Raised guidance plus strong margin expansion and a PFAS municipal contract are likely to support near-term sentiment, but North America auto weakness and international volume declines are key offsets.

    fool.com · Aug 8, 2026

  • This is a routine insider sale with no stated 10b5-1 plan, but it does not disclose new company fundamentals.

    SEC EDGAR · Aug 4, 2026

  • Guidance raise plus improved leverage supports a near-term positive repricing, but higher inventory and H2 margin pressure temper upside.

    yahoo.com · Aug 2, 2026

  • Raised full-year adjusted EBITDA guidance and improved adjusted EBITDA margin suggest strengthening cash generation and leverage reduction trajectory.

    SEC EDGAR 8-K · Jul 29, 2026

  • This is a governance/finance leadership change with specific compensation terms; it’s unlikely to move fundamentals immediately but can affect internal reporting/accounting oversight.

    SEC EDGAR 8-K · Jun 24, 2026

alphai scores every news story that mentions NGVT with an AI model for sentiment and relevance, and aggregates insider trades from Ingevity Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $NGVT

Score
$NGVTMedAI 8/10

Ingevity (NGVT) Q2 2026 Earnings Call Transcript

Ingevity (NGVT) held its Q2 2026 earnings call. Net sales were $314 million, down 5% on reported basis due to the Road Markings divestiture. Adjusted EBITDA rose 14% to $115 million, with margin at 36.6%. Adjusted EPS was $1.74. Free cash flow was $89 million. Full-year guidance for EBITDA and EPS was raised.

$NGVTMedAI 8/10

Ingevity Q2 Earnings Call Highlights

Ingevity (NYSE:NGVT) reported Q2 cash flow excluding a litigation settlement of about $89M, or $2.52/share, with capex near $10M. Performance Materials sales rose 4% to $161M, with segment EBITDA up 6% to $86M and margin to 53.6%. The company raised 2026 outlook to adjusted EBITDA $380M-$400M and EPS $5.00-$5.45, plus free cash flow $220M-$245M.

$NGVTMed

Ingevity Corp (NGVT): Results of Operations and Financial Condition

Ingevity Corp (NGVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99106302026.htm EX-99.1 Document Exhibit 99.1 Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Ingevity reports second quarter 2026 financial results Second Quarter 2026 Results and Recent Highlights: • Net sales of $31

$NGVTLow

Ingevity Corp (NGVT): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Ingevity Corp (NGVT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. ngvt-20260622 false Ingevity Corp 0001653477 0001653477 2026-06-22 2026-06-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 8-K _________________________________________________

Ingevity announces sale of Ozark Materials road markings business to PPG, strengthening strategic focus

Ingevity Corporation has announced the sale of its Ozark Materials road markings business to PPG for approximately $65 million, an all-cash transaction that has already closed. This divestiture allows Ingevity to sharpen its strategic focus on its core businesses, while PPG will integrate Ozark Materials into its existing pavement markings solutions. Ingevity plans to update its full-year 2026 financial guidance in conjunction with its first-quarter results to reflect the impact of this transaction.

NGVT Financials: Revenue Breakdown, Margins & Competitor Comparison

The article provides a financial overview of Ingevity Corp (NGVT), detailing its revenue breakdown, profitability margins, and a comparison with competitors. NGVT generates significant revenue from its Pavement Technologies and Industrial Specialties product lines, with a gross margin of 34.42%. Despite its leading market capitalization of $2.49B, the company reports negative net margins and Return on Equity, highlighting areas for investor consideration.

Related tickers